These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 23651025)
41. Pharmacogenetics as a tool for optimising drug therapy in solid-organ transplantation. Ng FL; Holt DW; MacPhee IA Expert Opin Pharmacother; 2007 Sep; 8(13):2045-58. PubMed ID: 17714059 [TBL] [Abstract][Full Text] [Related]
42. Pharmacogenomics and beyond! Customized pharmacotherapy for solid organ transplant recipients. Lemke A; Wright J; May H Pharmacotherapy; 2023 Jul; 43(7):596-608. PubMed ID: 36999337 [TBL] [Abstract][Full Text] [Related]
43. Pharmacogenetic differences and drug-drug interactions in immunosuppressive therapy. Warrington JS; Shaw LM Expert Opin Drug Metab Toxicol; 2005 Oct; 1(3):487-503. PubMed ID: 16863457 [TBL] [Abstract][Full Text] [Related]
44. Pharmacogenetics of immunosuppressants: progress, pitfalls and promises. Cattaneo D; Baldelli S; Perico N Am J Transplant; 2008 Jul; 8(7):1374-83. PubMed ID: 18510642 [TBL] [Abstract][Full Text] [Related]
45. Re: Transplantation between monozygotic twins: how identical are they? Goldfarb DA J Urol; 2015 Jan; 193(1):230. PubMed ID: 25523681 [No Abstract] [Full Text] [Related]
52. The role of genetics in drug dosing. Ware N Pediatr Nephrol; 2012 Sep; 27(9):1489-98. PubMed ID: 22358188 [TBL] [Abstract][Full Text] [Related]
53. What is the appropriate management, including drug therapy, for epilepsy in a child with a renal transplant? Robinson RO Pediatr Nephrol; 1993 Aug; 7(4):364. PubMed ID: 8398642 [No Abstract] [Full Text] [Related]
54. From pharmacokinetics to pharmacogenomics: a new approach to tailor immunosuppressive therapy. Cattaneo D; Perico N; Remuzzi G Am J Transplant; 2004 Mar; 4(3):299-310. PubMed ID: 14961981 [TBL] [Abstract][Full Text] [Related]
55. Genetics of drug response to immunosuppressive treatment and prospects for personalized therapy. Danesi R; Mosca M; Boggi U; Mosca F; Del Tacca M Mol Med Today; 2000 Dec; 6(12):475-82. PubMed ID: 11099953 [TBL] [Abstract][Full Text] [Related]
56. Use of pharmacogenomics in pediatric renal transplant recipients. Medeiros M; Castañeda-Hernández G; Ross CJ; Carleton BC Front Genet; 2015; 6():41. PubMed ID: 25741362 [TBL] [Abstract][Full Text] [Related]
57. Transplantation genetics: current status and prospects. Almoguera B; Shaked A; Keating BJ Am J Transplant; 2014 Apr; 14(4):764-78. PubMed ID: 24618335 [TBL] [Abstract][Full Text] [Related]
58. Introduction to genetic processes in transplantation. Santiago-Sim T; Colosimo S; Powner DJ Prog Transplant; 2012 Jun; 22(2):192-8; quiz 199. PubMed ID: 22878077 [TBL] [Abstract][Full Text] [Related]
59. The emerging role of gene polymorphisms determining outcome after solid-organ transplantation. Filler G; Hocher B Pediatr Transplant; 2002 Feb; 6(1):12-4. PubMed ID: 11906636 [No Abstract] [Full Text] [Related]
60. Pharmacogenomics of Old and New Immunosuppressive Drugs for Precision Medicine in Kidney Transplantation. Turolo S; Edefonti A; Syren ML; Montini G J Clin Med; 2023 Jul; 12(13):. PubMed ID: 37445489 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]